文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

老年癌症患者的PPT和VES-13:多维老年评估中的评估及生存预测

PPT and VES-13 in elderly patients with cancer: evaluation in multidimensional geriatric assessment and prediction of survival.

作者信息

Augschoell Julia, Kemmler Georg, Hamaker Marije E, Stauder Reinhard

机构信息

Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria.

Department of Biological Psychiatry, Innsbruck Medical University, Innsbruck, Austria.

出版信息

J Geriatr Oncol. 2014 Oct 1;5(4):415-21. doi: 10.1016/j.jgo.2014.08.005. Epub 2014 Sep 19.


DOI:10.1016/j.jgo.2014.08.005
PMID:25242575
Abstract

OBJECTIVES: The multidimensional geriatric assessment (MGA) detects impairments in the elderly and forms the basis for individualized treatment algorithms. Screening tools have been developed to detect patients in need of a full assessment. The aim of this pilot study was to evaluate the discriminative power and the prognostic impact of the screening scores for the Physical Performance Test (PPT) and the Vulnerable Elders Survey-13 (VES-13). MATERIALS AND METHODS: In 77 patients with cancer aged ≥60years (median 74years) from the Department of Internal Medicine V, Innsbruck Medical University, VES-13 and PPT were performed and compared with data from MGA and clinical outcomes. RESULTS: Overall, of the 77 patients 70% was deemed impaired, as defined by impairments in two or more scores of the MGA. The VES-13 showed 42% to be impaired, the PPT 79%. Using a cut-off of ≤19, the PPT exhibited better discriminative power than did the standard PPT (≤20). Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of VES-13, PPT≤20 and PPT≤19 in the detection of impairments were 56% (88%, 82%), 91% (45%, 75%), 94% (80%, 89%), and 45% (60%, 63%) respectively. The area under the curve was 0.73 (0.67, 0.79), respectively. Both impaired VES-13 and PPT significantly correlated with an unfavorable overall survival in both uni- and multivariate analysis. CONCLUSION: PPT (≤19) reveals favorable sensitivity, NPV and overall accuracy in elderly patients with cancer. Still, the NPV is too low to sufficiently discriminate between fit and frail patients. Both PPT and VES-13 are useful predictors for survival.

摘要

目的:多维老年评估(MGA)可检测老年人的功能障碍,并为个体化治疗方案提供依据。目前已开发出筛查工具,用于识别需要进行全面评估的患者。本试点研究旨在评估体能测试(PPT)和脆弱老年人调查-13(VES-13)筛查分数的鉴别能力和预后影响。 材料与方法:对因斯布鲁克医科大学内科V的77例年龄≥60岁(中位年龄74岁)的癌症患者进行VES-13和PPT测试,并与MGA数据及临床结局进行比较。 结果:总体而言,77例患者中,70%被判定存在功能障碍,定义为MGA中两项或以上分数存在功能障碍。VES-13显示42%的患者存在功能障碍,PPT显示79%的患者存在功能障碍。以≤19分为临界值时,PPT的鉴别能力优于标准PPT(≤20分)。VES-13、PPT≤20分和PPT≤19分在检测功能障碍方面的敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)分别为56%(88%,82%)、91%(45%,75%)、94%(80%,89%)和45%(60%,63%)。曲线下面积分别为0.73(0.67,0.79)。单因素和多因素分析均显示,VES-13和PPT功能障碍均与不良总生存期显著相关。 结论:PPT(≤19分)在老年癌症患者中显示出良好的敏感性、NPV和总体准确性。然而,NPV过低,不足以充分区分健康和虚弱患者。PPT和VES-13都是生存的有用预测指标。

相似文献

[1]
PPT and VES-13 in elderly patients with cancer: evaluation in multidimensional geriatric assessment and prediction of survival.

J Geriatr Oncol. 2014-10-1

[2]
A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation.

Cancer. 2007-2-15

[3]
Vulnerable Elderly Survey 13 as a screening method for frailty in Polish elderly surgical patient--prospective study.

Pol Przegl Chir. 2014-3

[4]
Gait Speed vs. VES-13: A Pilot Study Comparing Screening Tools to Determine the Need for a Comprehensive Geriatric Assessment in Senior Women with Breast Cancer.

J Med Imaging Radiat Sci. 2019-12

[5]
Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13.

J Clin Oncol. 2010-3-22

[6]
A Questionnaire Study to Assess the Value of the Vulnerable Elders Survey, G8, and Predictors of Toxicity as Screening Tools for Frailty and Toxicity in Geriatric Cancer Patients.

Oncol Res Treat. 2016-3-30

[7]
Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.

PLoS One. 2014-12-11

[8]
The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancy.

Ann Hematol. 2014-2-2

[9]
The importance of negative predictive value (NPV) of vulnerable elderly survey (VES 13) as a pre-screening test in older patients with cancer.

Med Oncol. 2013-8-31

[10]
Screening Performance for Frailty Among Older Patients With Cancer: A Cross-Sectional Observational Study of Two Approaches.

J Natl Compr Canc Netw. 2015-12

引用本文的文献

[1]
Cardiometabolic Disorders Are Important Correlates of Vulnerability in Hospitalized Older Adults.

Nutrients. 2023-8-25

[2]
Association of health vulnerability with adverse outcomes in older people with COVID-19: a prospective cohort study.

Clinics (Sao Paulo). 2021

[3]
Older adults with cancer and their caregivers - current landscape and future directions for clinical care.

Nat Rev Clin Oncol. 2020-12

[4]
Which better predicts mortality among older men, a prostate cancer (PCa) diagnosis or vulnerability on the Vulnerable Elders Survey (VES-13)? A retrospective cohort study.

J Geriatr Oncol. 2016-11

[5]
How should older adults with cancer be evaluated for frailty?

J Geriatr Oncol. 2017-1

[6]
Optimizing the G8 Screening Tool for Older Patients With Cancer: Diagnostic Performance and Validation of a Six-Item Version.

Oncologist. 2016-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索